The procurement of methamphetamine for approved research or therapeutic purposes presents particular hurdles for institutions. Ensuring compliance with federal statutes and stringent reporting requirements is necessarily essential. This system often involves detailed record keeping, careful inventory controls, and periodic audits. Moreover, institu